Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06172322
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-11-24
Brief Title:
A Phase Ibâ…¡ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive HER-2 Negative Breast Cancer
Sponsor:
Nanjing Chia-tai Tianqing Pharmaceutical
Organization:
Nanjing Chia-tai Tianqing Pharmaceutical
Organization Data
Organization:
Nanjing Chia-tai Tianqing Pharmaceutical
Class:
INDUSTRY
Study ID:
NTQ1062-BC-2023101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanjing Chia-tai Tianqing Pharmaceutical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None